New Drug "Cocktails" Prove Effective Against Hepatitis

n a daily dose of the Interferon alfa-2b and ribavirin (Rebetol) combinationfor 24 or 48 weeks, while the other half were given interferon alone.Those patients who received the combination did much better than those who didnot. According to the abstract of the research, the drug combination was "significantly more effective than Interferon alone." In addition, "This combination therapy has an acceptable safety profile."

Another study, presented at the AASLD Annual Meeting by Thierry Poynard, MD, of the Hepato Gastro Groupe Hospitale Pitie Salpetriere in Paris, examined the results of an International European trial of the Interferon alfa-2b and ribavirin combination as a treatment for chronic Hepatitis C. This study, too, found the combination to be effective. "Intron A[interferon]/Rebetol combination therapy was significantly more effective than Introl A monotherapy," according to the study abstract. "This is a huge breakthrough," says Poynard.

A third study, also presented by Poynard,unveiled the results of using the Interferon alfa-2b/ribavirin to treat liver fibrosis in Hepatitis C patients. The last stage of liver fibrosis in such patients is cirrhosis, which can be fatal. The huge study of almost 2,000 patients found that the combination of drugs reduces dramatically the rate of liver fibrosis progression. "This is now the most promising form of therapy," says Poynard. "It appears to be both effective and probably cost effective because of the reduction of cirrhosis incidence."

Possible Role of New TT-Virusin Liver Disease

Some 5% of liver disease is of unknown origin. A paper presented at the AASLD Annual meeting by Philip Adjei, Mayo Clinic, examined the possible role in liver disease played by a newly discovered single-strand DNA virus, TT-virus(TTV). Researchers studied patients who had received liver transplants and who showed no evidence of any of the known causes of liver disease. The patients were monitored bo

Contact: Kirk Monroe
American Association For The Study of Liver Diseases

Page: 1 2 3

Related biology news :

1. Proven method of bone analysis may clarify human origins
2. Researchers Prove Chemoprevention Can Work
3. Drug Combination May Prove Effective To Prevent Recurrence Of Hepatitis C After Transplantation
4. Penn Researchers Prove "Short-Cut" Function Of Myelin Sheath Channel: BetterUnderstanding Of Myelin Should Lead To Therapies For Neuropathies
5. Reengineered Poliovirus Proves Effective As Vector For Prompting Key Immune Response In A Study With Mice
6. Simplified Therapy To Prevent TB Proven Effective In Developing Countries
7. High Levels of Vitamin C Prove Toxic to HIV
8. Effective acne treatments remain elusive, Hopkins researchers find
9. Study Ensures Effective Ways To Measure Macular Pigment Density
10. Discovery Of 13 Genes Expressed In Brain Tumors May Lead To More Effective Diagnosis Or Prevention
11. New Drug Shown Effective Against Vancomycin-Resistant Bacteria

Post Your Comments:

(Date:7/17/2019)... ... July 17, 2019 , ... ... and its acclaimed pediatric urologists are among the professionals honored in U.S. ... signifies excellence among the country’s pediatric healthcare landscape. , Georgia Urology’s wholly-owned ...
(Date:7/10/2019)... ... July 10, 2019 , ... Inference ... and service organizations, today announced its role in Pizza Hut Australia’s digital ... of its franchisees. A key part of this initiative is implementation of an ...
(Date:6/27/2019)... ... 2019 , ... Lighting designers from integrated design firm LPA recently ... for creating both engaging and energy efficient lighting systems. , The lighting for the ... San Diego, California earned an IES Illumination Award of Merit in the Energy and ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... ... At the most recent stem cell training course in Las ... R3 Heroes Program. The Veterans included individuals and families from all over the US, ... a military Veteran, teacher or first responder to receive a regenerative therapy at a ...
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/11/2019)... ... June 10, 2019 , ... DeepDyve ... of its scientific journals to DeepDyve’s rental service for peer-reviewed journals. , ... library of more than 20 million articles, sourced from more than 15,000 journals. ...
(Date:5/31/2019)... ... ... For many years, the primary forms of cancer treatment have been chemotherapy, ... immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) cell ... as “CARs”. The CAR enables the final product to produce chemicals in the hopes ...
Breaking Biology Technology:
Cached News: